Karel Opatrný Jr.

Tissue-Type Plasminogen Activator (tPA) and Its Inhibitor (PAI-1) in Patients Treated with Continuous Ambulatory Peritoneal Dialysis

S. Opatrná, K. Opatrný, Karel Opatrný Jr., 1998, American Journal of Nephrology.

The Effect of Intravenous Iron on Oxidative Stress in Hemodialysis Patients at Various Levels of Vitamin C

J. Rácek, L. Trefil, P. Stehlík, 2006, Blood Purification.

Prospective Comparison of Valacyclovir and Oral Ganciclovir for Prevention of Cytomegalovirus Disease in High-Risk Renal Transplant Recipients

T. Reischig, V. Treska, J. Mareš, 2005, Kidney and Blood Pressure Research.

Fibrinolysis Defect in Long-Term Hemodialysis Patients with Type 2 Diabetes mellitus and Its Relation to Metabolic Disorders

S. Massry, J. Mareš, S. Opatrná, 2002, American Journal of Nephrology.

Tissue Factor, Its Pathway Inhibitor, and Metabolic Disturbances in Long-Term Peritoneal Dialysis

J. Rácek, S. Opatrná, P. Zemanová, 2003, Kidney and Blood Pressure Research.